Scholar Rock Holding Corp - 8-K Filing
Scholar Rock's FDA-approved drug ISEMBYLD requires post-marketing pregnancy safety study and fracture reporting (Items: 7.01 Regulation FD Disclosure)
Tickers: $SRRK
More Regulatory news
- Neonode Inc. - 8-K Filing
- Beyond Air, Inc. - 10-Q Filing
- Carter Bankshares, Inc. - 8-K Filing
- Marvell Technology, Inc. - 8-K Filing
- VISHAY INTERTECHNOLOGY INC - 8-K Filing
- LATTICE SEMICONDUCTOR CORP - 4 Filing
- CENTRUS ENERGY CORP - 8-K Filing
- SAGA COMMUNICATIONS INC - 8-K Filing
- NextBoat Inc. - 8-K Filing
- CIVISTA BANCSHARES, INC. - 8-K Filing